Policy / Pricing RFK Jr. rewrites ACIP rules; Gilead, Roche dig into protein degraders pharminent April 10, 2026
Policy / Pricing The FTC Blows Up Express Scripts’ PBM Model–and Launches the Net Pricing Drug Channel (rerun) pharminent April 9, 2026
Policy / Pricing List Price Reductions Will Deflate the Gross-to-Net Bubble-and Threaten Pharmacy and 340B Profits from IRA-Negotiated Drugs (rerun) pharminent April 8, 2026
Policy / Pricing AbbVie Puts Humira on TrumpRx at Steep Discount as Tariff Threat Solidifies pharminent April 7, 2026
Policy / Pricing FDA floats new clinical trial reforms; Takeda punts Denali brain drug pharminent April 6, 2026
Policy / Pricing Trump revives pharma tariffs with 100% charges, but leaves loopholes pharminent April 3, 2026
Policy / Pricing Trump Hits Drugmakers With 100% Tariff but Carve-outs Soften the Blow pharminent April 3, 2026
Policy / Pricing Rare Disease Leaders Call for Regulatory Clarity as FDA Balances Urgency With Rigor pharminent April 2, 2026
Policy / Pricing Pharma’s Reluctance To Serve Europe To Dodge MFN Drug Pricing Is Chilling pharminent April 2, 2026
Policy / Pricing A ‘hijacked plane’: CDC, under RFK Jr.’s influence, trades science for dogma pharminent April 1, 2026
